Navigation Links
Florida Prostate Cancer Specialist Challenges Robotic Surgical System as a Boondoggle for Healthcare
Date:8/5/2014

CORAL SPRINGS, Fla., Aug. 5, 2014 /PRNewswire/ -- A prominent Florida prostate cancer specialist is leading a groundswell of physicians and prostate cancer patients challenging the efficacy of a popular robotic surgical treatment marketed and promoted into near ubiquitous use in hospitals across the nation.

In an extensive article http://www.urologyweb.com/robotic-prostate-cancer-surgery-a-public-health-nightmare/, Urologist Dr. Bert Vorstman details "Robotic Prostate Cancer Surgery: A Public Health Nightmare", the story behind prostate cancer and the industry that has been built around it.

Dr. Vorstman slammed the over-diagnosis and over-treatment of prostate cancers and called the radical prostatectomies performed by robotic procedures a "boondoggle for healthcare".

"Not only does this robotic prostatectomy lack scientific data to prove its safety and benefit for prostate cancer treatment but the very common so-called Gleason 6 (3+3) prostate "cancer" needs no treatment because on both clinical and molecular biology grounds, it behaves as noncancerous and is not a health risk," said Dr. Vorstman.  "Instead, most men with a prostate cancer label are over-treated for zero benefit, resulting in a trail of broken patients with bad postoperative outcomes including urinary incontinence and impotence.  Because of a lack of sincere regulatory oversight, this robotic procedure has generated many product liability lawsuits."

Dr. Vorstman's comments join with a growing chorus of those decrying the lack of benefits for PSA prostate cancer screening along with the lifelong harms associated with treatment and especially surgery.  Included are the Chief Medical and Scientific Officer of the American Cancer Society, Otis Brawley MD, author of  "How We Do Harm"; Anthony Horan MD, author of "How to Avoid the Over-Diagnosis and Over-Treatment of Prostate Cancer; Richard J. Albin, the discoverer of the PSA test and co-author (with Ron Piana) of "The Great Prostate Hoax"; L. Klotz MD, who underscored that molecular and clinical research showed the Gleason 6 (3+3) "cancer" to lack the hallmarks of cancer; the US Preventive Services Task Force (USPSTF), which reported on the absence of benefits for PSA screening for the treatment of screen-detected prostate cancer; and the numerous victims of the brutal radical prostatectomy who suffered the many after-effects but no benefits.

"The Journal of the American Medical Association warned of a 'Gizmo Idolatry' in a 2008 editorial and I'm afraid that's where we stand today with robotic prostate surgery," said Dr. Vorstman, who has long advocated patient rights and full disclosure in treatment procedures. "Again, the approval of robotics for prostate cancer treatment is yet another shining example of junk science and greed influencing "new research" to justify old, ill-conceived treatment philosophies."

"Robotic prostatectomy has been mass marketed, heavily promoted for patient exploitation and now has become a profit center for medical facilities and hospitals at patient expense," said Dr. Vorstman.  "As well, with robotic surgical systems costing close to $2 million, plus a $150,000 per year service contract, this preoccupation with patient exploitation has led physicians and hospitals to create their own supply and demand as well as squander endless sums of precious healthcare dollars on mostly insignificant prostate cancers."

"This intentionally misleading, broad-brush labeling of every prostate cancer as though it were some fast moving, potential killer cancer when only some prostate cancers exhibit this potential, requires urgent correction to stop the many unscrupulous physicians misleading men about their cancer and the debilitating robotic treatment purposefully for self-gain," he added.


'/>"/>
SOURCE Dr. Bert Vorstman
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. DNA Diagnostics Center - Forensics Proved Florida Mans Innocence After Being Wrongfully Imprisoned for Nine Years
2. Florida Attorney Gary M. Farmer, Jr. Settles Third Whistleblower Drug Case for $1.27 Billion
3. Biotest Opens New Plasma Center in Melbourne, Florida
4. MinuteClinic Signs Clinical Collaboration with Baptist Health Care for Clinic Locations in Three-County Region of Northwest Florida
5. Senator Shares Insight on Florida Physician Dispensing Legislation as First Guest of Progressive Medicals New SignatureSeries
6. Central Florida Plastic Surgeon and Fat Grafting Pioneer to Present at Berlin Conference
7. Lupus Foundation of Florida Applauds Support for Biosimilars Legislation
8. Joint Implant Surgeons of Florida Deploys RTLS Patient Work-flow Management Solution to Improve Efficiency and Patient Experience
9. New Florida Peptides Site offering CJC-1295, GHRP-6, Sermorelin and more!
10. Only Podiatric Surgeon In S. Florida That Performs In-Office Ultrasound Imaging On Foot & Ankle Problems Saving Patients Over $1,000 In MRI Expenses & Extra Trip To Hospital
11. Now Available in South Florida: CentraSight Treatment Program Offers New Hope for Patients with End-Stage Macular Degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient ... bei Brustkrebs   QIAGEN N.V. (NASDAQ: ... gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit ... Assays für die Onkologie eingegangen zu sein. Ein ...
(Date:5/25/2016)... May 25, 2016 As illustrated ... earlier this month, the numbers and momentum of cannabis ... climb into the billions, more research and development push ... Edition State of Legal Marijuana Markets Report  from from ... firm, much of the increase in sector is attributed ...
(Date:5/25/2016)... , May 25, 2016 ... H1 2016"market research report that provides an overview ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in the health care ... leaders in the nursing and health care industry. It also provides insight to the ... University. , As the nursing industry is coming out of one of the ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at a ... to wait until March 2017 for an interest rate increase, according to Rajeev Dhawan ... Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest to ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
Breaking Medicine News(10 mins):